Komori
Nihon Trim (6788) · InitiativeAdded with medical-device commercialization and overseas expansion in mindLatest Earnings presentation materials (2026-08-06): "Worsened"

Full-scale rollout of the electrolysis water dialysis system

First written in FY2016. 28 of 37 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-08-06.

37entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018-Q2 – FY2024-Q2AdvancedFY2025-H1 – 2026-05-132016: 320162017: 420172018: 420182019: 320192020: 420202021: 220212022: 420222023: 420232024: 320242025: 220252026: 42026
Same theme, other companies
Commercialisation and rollout of an electrolysed-water dialysis systemA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Added with medical-device commercialization and overseas expansion in mindAnnual report

    「We will continue accumulating clinical data and pursue further research and development, with the conversion of the system into a medical device and overseas expansion also in view. We aim to expand adoption as the next-generation global standard therapy.」

    For electrolyzed water dialysis, the company has added the conversion of the system into a medical device and overseas expansion to its research and development agenda, in addition to continued adoption in Japan.
  2. 2026-05-13AdvancedEarnings

    「Electrolyzed-water dialysis has now been introduced at 37 facilities, including 3 newly added during the current fiscal year, with 1,127 beds. Approximately 3,400 people are receiving electrolyzed-water dialysis treatment.」

    The company updated its implementation record to 37 facilities, 1,127 beds and approximately 3,400 patients. It also expects 5 new facilities to adopt the system in FY2027.
  3. FY2026-H1AdvancedAnnual report

    「In the electrolyzed water dialysis business, following installations in June this year, new installations were completed at 2 facilities in July and September, comprising 1 multi-patient facility and 1 individual-use facility. The number of facilities using electrolyzed water dialysis has now reached 37, with 1,127 beds. Approximately 3,400 people are receiving treatment.」

    Two facilities were newly added, increasing the installation record from 34 facilities, 1,030 beds and approximately 3,000 patients to 37 facilities, 1,127 beds and approximately 3,400 patients.
  4. FY2025AdvancedAnnual report

    「In the electrolyzed water dialysis business, systems were installed at 3 facilities during the current fiscal year, and revenue increased to ¥108 million, up 79.2% year on year. The number of facilities using electrolyzed water dialysis reached 34, with 1,030 beds, and approximately 3,000 dialysis patients are receiving “Electrolyzed Water Dialysis.”」

    Three facilities were newly added during the fiscal year, bringing the cumulative total to 34 facilities and 1,030 beds, approximately 3,000 treated patients and revenue of ¥108 million.
  5. FY2025-H1AdvancedAnnual report

    「In the electrolyzed water dialysis business, following the 69th Annual Meeting of the Japanese Society for Dialysis Therapy in June this year, we are actively conducting sales activities, including exhibiting at the 35th Annual Meeting of the Japanese Society for Blood Purification in Critical Care, to be held in October, and the 30th Annual Meeting of the Japanese Society for Hemodiafiltration, to be held in November. Awareness and interest in electrolyzed water dialysis are steadily increasing, and we will continue to expand them. We are also working on developing new equipment to promote adoption.」

    The company has advanced to the stage of conducting sales activities through exhibitions at multiple dialysis-related academic conferences and developing new equipment to promote adoption.
  6. FY2024SoftenedAnnual report

    「In the electrolyzed water dialysis business, 4 facilities originally expected to be installed during the current fiscal year were postponed to the next fiscal year or later due to circumstances on the facilities’ side. As a result, installation was limited to multi-patient systems at 2 facilities, Shonan Kamakura General Hospital of the Tokushukai Group and Tokyo Nephro Clinic, and revenue was ¥60 million, down 48.0% year on year.」

    Installation at 4 facilities expected during the current fiscal year was postponed to the next fiscal year or later. Installation was therefore limited to 2 facilities, and revenue was ¥60 million, down 48.0% year on year.
  7. FY2024-Q3Plans for holding research meetings made more concreteAnnual report

    「In the electrolyzed water dialysis business, we are working to expand our activities through seminars held by nephrology-related academic societies and clinical engineering technologists’ associations nationwide, while strengthening cooperation with distributors and focusing on developing new opportunities. We are also conducting public-relations activities to raise awareness among dialysis patients. The first Electrolyzed Water Dialysis Research Meeting and Scientific Conference is scheduled for 7 July this year under the theme “15 Years Since the Clinical Introduction of Electrolyzed Water Dialysis: The Beginning of Chapter 2 of Electrolyzed Water Dialysis.”」

    In addition to seminars at academic societies and clinical engineering technologists’ associations, cooperation with distributors and patient-focused public relations, the company indicated plans to hold the first Electrolyzed Water Dialysis Research Meeting and Scientific Conference on 7 July 2024. The event was described as a future plan and not as having already taken place.
  8. FY2024-Q2AdvancedAnnual report

    「In the electrolyzed water dialysis business, we are advancing discussions with facilities that showed positive interest in installation at the 68th Annual Meeting of the Japanese Society for Dialysis Therapy, held in June this year at the Kobe International Convention Center. We are also working to expand our activities by holding seminars through the Japanese Society of Nephrology, the Japanese Society of Renal Rehabilitation and clinical engineering technologists’ associations nationwide, while strengthening cooperation with distributors and focusing on developing new opportunities.」

    The company is advancing discussions with facilities that expressed interest at the dialysis medicine conference and expanding its activities to seminars held by the Japanese Society of Nephrology and other organizations and by clinical engineering technologists’ associations, as well as developing new opportunities through cooperation with distributors.
  9. FY2024-Q1AdvancedAnnual report

    「In the electrolyzed water dialysis business, systems were newly installed at Shonan Kamakura General Hospital of the Tokushukai Group and Tokyo Nephro Clinic during the first quarter of the current fiscal year. As of the end of June, approximately 2,900 patients were receiving treatment at 32 facilities with 961 beds.」

    The system was newly installed at 2 facilities, bringing the installation record to 32 facilities and 961 beds and the number of treated patients to approximately 2,900.
  10. FY2023AdvancedAnnual report

    「As of the end of April 2023, electrolyzed water dialysis systems had been installed at 32 of Japan’s 4,493 dialysis facilities, covering 945 beds, and approximately 2,800 patients were receiving treatment. In the fiscal year ending March 2024, installation at additional facilities within the Tokushukai Group is planned following installation at Yamauchi Hospital during the current fiscal year.」

    The installation record increased from 29 facilities, 929 beds and approximately 2,700 patients to 32 facilities, 945 beds and approximately 2,800 patients. Additional installations within the Tokushukai Group were also indicated.
  11. FY2023-Q3AdvancedAnnual report

    「Electrolyzed water dialysis has now been installed at 29 facilities with 929 beds, and approximately 2,700 patients are receiving treatment. Installation at 5 additional facilities is planned for the fourth quarter, comprising 3 multi-patient facilities and 2 individual-use facilities.」

    The electrolyzed water dialysis installation record was updated to 29 facilities, 929 beds and approximately 2,700 patients, with plans announced to add 5 facilities in the fourth quarter.
  12. FY2023-Q2AdvancedAnnual report

    「Electrolyzed water dialysis has now been installed at 29 facilities with 929 beds, and approximately 2,700 patients are receiving treatment. Two new facilities were added in the first half, and 6 installations are currently planned for the second half. From the next fiscal year onward, we are also submitting estimates and holding detailed discussions with more than 60 facilities. Japan has approximately 4,500 dialysis facilities, and we will continue to focus on expanding adoption.」

    Electrolyzed water dialysis expanded to 29 facilities, 929 beds and approximately 2,700 patients, with 2 facilities newly added in the first half. Discussions are under way with 6 facilities for the second half and more than 60 facilities from the next fiscal year onward.
  13. FY2023-Q1AdvancedAnnual report

    「In May this year, our electrolyzed water dialysis system was installed at the new dialysis center of Kameda General Hospital, operated by Medical Corporation Tetsukaikai and serving as a key hospital in the Minamiboso area of Chiba Prefecture. In July, it was installed at Ishida Clinic, operated by Medical Corporation Yujinkai and serving as a leading dialysis facility in the Nakashari area of Hokkaido. Currently, approximately 2,700 patients are receiving electrolyzed water dialysis treatment at 29 facilities with 929 beds.」

    Following installations at Kameda General Hospital and other facilities, the installation record increased from 27 facilities, 799 beds and approximately 2,400 patients to 29 facilities, 929 beds and approximately 2,700 patients.
  14. FY2022RaisedAnnual report

    「As a first step, we aim to install the system at 300 facilities, approximately 7% of Japan’s roughly 4,500 facilities. We also aim to develop it into a global standard beyond Japan.」

    The installation target for the electrolyzed water dialysis system has been raised from the previous 100 facilities to 300 facilities, equivalent to approximately 7% of Japan’s roughly 4,500 facilities.
  15. FY2022-Q3AdvancedAnnual report

    「In the electrolyzed water dialysis business, approximately 2,400 or more patients are currently receiving treatment at 27 facilities with 799 beds. We have submitted estimates to 57 facilities that are currently in detailed discussions and have a high likelihood of concluding contracts within 2 years, representing total potential sales of approximately ¥1.1 billion.」

    The installation record increased from 25 facilities, 727 beds and approximately 2,200 or more patients to 27 facilities, 799 beds and approximately 2,400 or more patients. Discussions have advanced with 57 facilities that have a high likelihood of concluding contracts within 2 years, representing total potential sales of approximately ¥1.1 billion.
  16. FY2022-Q1AdvancedAnnual report

    「Currently, approximately 2,200 patients or more are receiving electrolyzed water dialysis treatment at 25 facilities with 727 beds. This exceeds the approximately 720 patients receiving home dialysis, approximately 600 receiving long-hours dialysis and approximately 1,860 receiving PD-HD hybrid therapy, all of which are established dialysis therapies, demonstrating steady expansion as a new treatment method.」

    The electrolyzed water dialysis installation record was updated to 25 facilities, 727 beds and more than approximately 2,200 patients, with comparisons also provided against other new dialysis therapies.
  17. FY2021AdvancedAnnual report

    「The electrolyzed water dialysis system had been installed at 25 of Japan’s 4,487 dialysis facilities as of 31 March 2021, according to the Japanese Society for Dialysis Therapy’s “Current Status of Chronic Dialysis Therapy in Japan as of 31 December 2019,” published by the General Incorporated Association. Our initial goal is to reach 100 facilities.」

    The installation record for the electrolyzed water dialysis system was updated to 25 facilities as of 31 March 2021, and the target of 100 facilities was reaffirmed.
  18. FY2021-Q2AdvancedAnnual report

    「In the electrolyzed water dialysis business, following the installation in June of a multi-patient electrolyzed water dialysis system with 45 beds at St. Luke’s International Hospital, 2 systems were installed in August at a major dialysis hospital in the Tokai region, with capacities of 90 beds and 63 beds.」

    Following St. Luke’s International Hospital, 2 systems totaling 153 beds were installed at a major dialysis hospital in the Tokai region in August.
  19. FY2021-Q1AdvancedAnnual report

    「In the electrolyzed water dialysis business, a multi-patient electrolyzed water dialysis system was installed in June at St. Luke’s International Hospital, a core facility in the Kanto region. Significant follow-on effects are expected.」

    A multi-patient system was installed at St. Luke’s International Hospital, a core facility in the Kanto region, marking tangible progress in installations.
  20. FY2020AdvancedAnnual report

    「In the electrolyzed water dialysis business, we promoted the system by highlighting a joint paper with Tohoku University and the improvement in hospital profitability resulting from its installation. As a result, the system was installed at 9 facilities during the fiscal year, and revenue rose to ¥139 million, up 755.9% year on year. Of Japan’s 4,458 dialysis facilities, the system had been installed at 23 facilities as of 31 March 2020. Our initial goal is to reach 100 facilities.」

    The system was installed at 9 facilities during the fiscal year, bringing the cumulative total to 23 facilities as of 31 March 2020. The company explicitly stated an installation target of 100 facilities.
  21. FY2020-Q3AdvancedAnnual report

    「In the electrolyzed water dialysis business, we are proceeding with installations at leading facilities that could serve as hubs in the Kanto and Kansai regions. We will continue to focus on sales activities and aim to install the system at 100 facilities within 3 years, as targeted by the company.」

    The company is proceeding with installations at leading facilities in the Kanto and Kansai regions and continues its sales activities toward its existing target of installations at 100 facilities within 3 years.
  22. FY2020-Q2AdvancedAnnual report

    「The electrolyzed water dialysis business has begun generating results, with revenue of ¥91 million. We are actively developing sales during the second half and from the next fiscal year onward to further expand performance. We are in discussions with approximately 100 facilities for installation within 3 years; if contracts are concluded with all of them, sales would be approximately ¥2.8 billion.」

    The electrolyzed water dialysis business recorded revenue of ¥91 million and advanced to discussions with approximately 100 facilities targeting installation within 3 years, representing potential sales of approximately ¥2.8 billion if all contracts are concluded.
  23. FY2020-Q1AdvancedAnnual report

    「In the electrolyzed water dialysis business, the system has now been installed at 19 facilities with 467 beds. We are actively holding luncheon seminars at nephrology and dialysis-related academic conferences to raise awareness further and expand adoption.」

    The installation record for the electrolyzed water dialysis system reached 19 facilities and 467 beds, and the company continues awareness-building and adoption initiatives through luncheon seminars at academic conferences.
  24. FY2019-Q3AdvancedAnnual report

    「In the healthcare-related business, we continue to focus on sales activities at dialysis facilities nationwide for the electrolyzed water dialysis business. We are currently in discussions with approximately 300 facilities.」

    The number of facilities in discussions regarding electrolyzed water dialysis reached approximately 300, up from 250 hospitals previously. Sales activities at dialysis facilities nationwide are continuing.
  25. FY2019-Q2AdvancedAnnual report

    「In the electrolyzed water dialysis business, systems were newly installed at 3 hospitals during the first half of the fiscal year, and installations at a further 6 hospitals are currently expected by the end of the fiscal year. The business is becoming increasingly active. We are currently in discussions with 250 hospitals.」

    The system was newly installed at 3 hospitals in the second quarter, with installations at a further 6 facilities expected during the current fiscal year. The number of hospitals in discussions reached 250.
  26. FY2019-Q1AdvancedAnnual report

    「The number of hospitals currently in discussions regarding installation is also increasing steadily, reaching 205 as of now. If all were to conclude contracts, expected sales would be approximately ¥4.5 billion. Because the electrolyzed water dialysis system represents a capital investment for medical facilities, some installations may not take place for several years. We will nevertheless strengthen our sales organization and work diligently to expand adoption. We aim to develop the system into the next global standard.」

    The number of hospitals in discussions regarding electrolyzed water dialysis installation reached 205, with expected sales of approximately ¥4.5 billion if contracts are concluded. The company is strengthening its sales organization and pursuing broader adoption.
  27. FY2018AdvancedAnnual report

    「In fact, prompted by this paper, a multi-patient system was installed at a dialysis clinic in Kyoto in March this year, and installation was also approved at a major hospital in Osaka. Electrolyzed water dialysis has now been introduced at 13 facilities, with 299 beds, comprising 3 facilities in Hokkaido, 3 in Tohoku, 1 in Kanto, 5 in Tokai and 1 in Kansai.」

    Installation at a dialysis clinic in Kyoto and the decision to install the system at a major hospital in Osaka indicate progress, bringing the installation record to 13 facilities and 299 beds.
  28. FY2018-Q3AdvancedAnnual report

    「In the electrolyzed water dialysis business, we are strengthening our sales activities, using the publication of the above-mentioned paper in “Scientific Reports” as a tailwind. Japan currently has approximately 340,000 dialysis patients and 4,396 dialysis facilities. As a first step, we are focusing on proposals to large hospitals that could serve as core facilities in the Kanto and Kansai regions.」

    Following publication of the paper, the company has defined its sales focus more specifically around proposals to large hospitals in the Kanto and Kansai regions, targeting a domestic market of approximately 340,000 dialysis patients and 4,396 facilities.
  29. FY2018-Q2AdvancedAnnual report

    「In the electrolyzed water dialysis business, we are focusing on sales activities following the strong response to our research presentation at the 62nd Annual Meeting of the Japanese Society for Dialysis Therapy in June this year. We have currently received orders worth more than ¥60 million. We will continue to pursue the business vigorously with the aim of making a further contribution to performance.」

    Following the research presentation at the Japanese Society for Dialysis Therapy, the company has advanced its sales activities and reached the stage of receiving orders worth more than ¥60 million.
  30. FY2018-Q1RestatedAnnual report

    「For “Electrolyzed Water Dialysis®,” we are strengthening our operations centered on electrolyzed water dialysis units and focusing on sales activities.」

    The company continues to strengthen its operations centered on electrolyzed water dialysis units and focus on sales activities.
  31. FY2017AdvancedAnnual report

    「In the electrolyzed water dialysis business, we have established a new electrolyzed water dialysis unit and begun full-scale sales activities, while also making significant progress in academic research.」

    The company has established a new electrolyzed water dialysis unit, stepped up its sales activities and reached the stage where it expects a contribution to earnings from the fiscal year ending March 2018.
  32. FY2017-Q3AdvancedAnnual report

    「For the new dialysis therapy “Electrolyzed Water Dialysis®,” we began selling a new electrolyzed water dialysis system last September and have been working vigorously toward full-scale adoption, including by strengthening our sales organization. Because the system represents a capital investment for hospitals, the process takes time and there is a lag between receiving an order and recognizing revenue, but we expect it to contribute to earnings in the next fiscal year.」

    Following the launch of the new system, the company has strengthened its sales organization and reached the stage where it expects a contribution to earnings in the next fiscal year.
  33. FY2017-Q2AdvancedAnnual report

    「In September this year, we began selling a new electrolyzed water dialysis system. Compared with the previous model, it is smaller, has enhanced hot-water disinfection capabilities and generates electrolyzed reverse-osmosis water with a stable dissolved hydrogen concentration that is less affected by the installation environment. Electrolyzed water dialysis is currently being provided at 15 facilities with 254 beds. We have also strengthened our sales organization and are working vigorously toward full-scale adoption.」

    Sales of the new electrolyzed water dialysis system began in September 2016, and it has been installed at 15 facilities with 254 beds.
  34. FY2017-Q1SoftenedAnnual report

    「A new device is currently scheduled for launch, and is expected to contribute to earnings from the second half of the current fiscal year.」

    The previous wording specified June as the planned month for beginning sales of the new device, whereas this time the launch timing is not specified, with earnings contribution expected from the second half of the current fiscal year.
  35. FY2016First statedAnnual report

    「We plan to begin selling a new device for the electrolyzed-water dialysis business in June this year. It is an innovative product that overcomes the challenges of existing devices, putting full-scale rollout within reach. 「Electrolyzed-Water Dialysis®」 has been introduced at an increasing number of facilities and is now available at 15 facilities nationwide, covering 251 beds.」

    The new device was scheduled for launch in June 2016, and existing adoption was reported at 15 facilities and 251 beds.
Moved together

"Storage, research and provision to medical institutions of cord blood-derived stem cells" moved the same way as this thread, in the same document, in 24 of its 37 moves.

242222212019★123456
  1. ★This thread
  2. 1Storage, research and provision to medical institutions of cord blood-derived stem cells24×
  3. 2Expansion of Overseas Sales Channels and Production Facilities, Centered on Indonesia22×
  4. 3Expansion of cord blood bank storage capacity22×
  5. 4Clarification of the functions of electrolyzed hydrogen water and differentiation from other types of water21×
  6. 5Strengthening Sales Capabilities and Improving Sales Efficiency20×
  7. 6Clinical Evidence for Electrolyzed Water Hemodialysis and Raising Awareness19×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nihon Trim yet. It last moved in the Earnings presentation materials of 2026-08-06: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Full-scale rollout of the electrolysis water dialysis system | NIHON TRIM CO.,LTD. (6788) | Komori